Heart Failure & Atrial Fibrillation

A Dangerous Cycle Driving Symptom Progression, Hospitalizations, and Poor Long-Term Outcomes

Atrial Synchronization for AF-HFpEF

A non-destructive, multi-mode therapy designed to restore sinus rhythm and optimize atrial function in heart failure patients with atrial fibrillation (AF-HFpEF).

Breaking the AF-HFpEF Cycle

  • AF worsens heart failure by disrupting atrial function, increasing congestion, and reducing cardiac efficiency. Restoring sinus rhythm and atrial synchrony is essential to improving outcomes and quality of life.

    Maxwell is Developing “Rhythm360” for AF-HFpEF Patients

  • Sustained Sinus Rhythm – Continuous intra-cardiac monitoring enables imperceptible AF termination and adaptive therapy adjustments.

  • Atrial Synchrony – Coordinated contraction of the left and right atria enhances cardiac efficiency, leading to improved heart failure outcomes.

  • Preserve, Don’t Destroy – Prevent and restore without the need for tissue destruction.

  • Exciting News from MaxWell Biomedical!

    Maxwell Biomedical is expanding its ongoing clinical study to further validate the groundbreaking Spatial Resynchronization Therapy (SRT) for patients with atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF).
    SRT is designed to imperceptibly terminate AF and restore atrial function and atrial synchrony —a non-destructive, next-generation approach that sets it apart from conventional ablation therapies. With this expansion, we aim to accelerate clinical insights, broaden patient access, and drive a paradigm shift in AF treatment for the AF-HFpEF population.

    Why It Matters:
    ·        Better Outcomes – SRT enhances atrial heart function while preventing AF, addressing a critical unmet need.
    ·        Expanded Study Scope – More patients, more data, stronger clinical validation.
    ·        Innovative Non-Destructive Approach – Unlike ablation, SRT does not destroy cardiac tissue but restores atrial conduction.

    As we take this next step, we’re grateful for our investors, clinical partners, and dedicated team members working to bring a new era of AF treatment to patients worldwide.

    Stay tuned for more updates!
    March 13, 2025

Active Atrial Fibrillation Management

Transforming AF Care: A Device Approach That Overcomes Past Limitations

Maximum Wellness

[ mak-suh-muhm ] [ wel-nis ]

Decades of AF Treatment Have Focused Soley on Tissue Destruction

Medicine Evolves: 🟥 Cox-Maze Surgery (1980s) →🟧 Catheter Ablation (1990s–Present) →🟩 Non-destructive (Future)